Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03637543
Title Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Beth Israel Deaconess Medical Center
Indications

prostate adenocarcinoma

Therapies

Nivolumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.